196 related articles for article (PubMed ID: 17496331)
1. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer.
Chen R; Brentnall TA; Pan S; Cooke K; Moyes KW; Lane Z; Crispin DA; Goodlett DR; Aebersold R; Bronner MP
Mol Cell Proteomics; 2007 Aug; 6(8):1331-42. PubMed ID: 17496331
[TBL] [Abstract][Full Text] [Related]
2. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
3. A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.
Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
JOP; 2013 Jul; 14(4):405-14. PubMed ID: 23846938
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
Saraswat M; Joenväärä S; Seppänen H; Mustonen H; Haglund C; Renkonen R
Cancer Med; 2017 Jul; 6(7):1738-1751. PubMed ID: 28573829
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.
Chen R; Pan S; Cooke K; Moyes KW; Bronner MP; Goodlett DR; Aebersold R; Brentnall TA
Pancreas; 2007 Jan; 34(1):70-9. PubMed ID: 17198186
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.
Paulo JA; Kadiyala V; Lee LS; Banks PA; Conwell DL; Steen H
J Proteome Res; 2012 Mar; 11(3):1897-912. PubMed ID: 22243521
[TBL] [Abstract][Full Text] [Related]
7. Proteomics as a systems approach to pancreatitis.
Williams JA
Pancreas; 2013 Aug; 42(6):905-11. PubMed ID: 23851428
[TBL] [Abstract][Full Text] [Related]
8. Proteomics portrait of archival lesions of chronic pancreatitis.
Pan S; Chen R; Stevens T; Bronner MP; May D; Tamura Y; McIntosh MW; Brentnall TA
PLoS One; 2011; 6(11):e27574. PubMed ID: 22132114
[TBL] [Abstract][Full Text] [Related]
9. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
10. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
13. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
Chou CY; Chang CT; Chen CJ
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).
Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
J Proteomics; 2013 Oct; 92():216-27. PubMed ID: 23500127
[TBL] [Abstract][Full Text] [Related]
15. NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
Olakowski M; Tyszkiewicz T; Jarzab M; Król R; Oczko-Wojciechowska M; Kowalska M; Kowal M; Gala GM; Kajor M; Lange D; Chmielik E; Gubala E; Lampe P; Jarzab B
Folia Histochem Cytobiol; 2009; 47(2):249-55. PubMed ID: 19995712
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer.
Hao C; Li Z; Zhang X; Zhang H; Shang H; Bao J; Wang H
Minerva Endocrinol; 2018 Sep; 43(3):253-258. PubMed ID: 29125273
[TBL] [Abstract][Full Text] [Related]
17. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
18. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.
Lukic N; Visentin R; Delhaye M; Frossard JL; Lescuyer P; Dumonceau JM; Farina A
Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482
[TBL] [Abstract][Full Text] [Related]
19. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
Birk D; Gansauge F; Gansauge S; Formentini A; Lucht A; Beger HG
Int J Pancreatol; 1999 Apr; 25(2):89-96. PubMed ID: 10360220
[TBL] [Abstract][Full Text] [Related]
20. Early changes in the urine proteome in a diethyldithiocarbamate-induced chronic pancreatitis rat model.
Zhang L; Li Y; Gao Y
J Proteomics; 2018 Aug; 186():8-14. PubMed ID: 30044967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
